For example, the oncogene Multiple Copies in T-cell Malignancy-1 (MCT-1), a recently identified prognostic biomarker in aggressive breast cancers, stimulates M2 macrophages in the tumor microenvironment through stimulation of IL-6. This evidence concerns the gene IL6 and breast carcinoma.